Literature DB >> 24402620

Bone density and fractures in autosomal dominant hyper IgE syndrome.

Kathryn J Sowerwine1, Pamela A Shaw, Wenjuan Gu, Jennifer C Ling, Michael T Collins, Dirk N Darnell, Victoria L Anderson, Joie Davis, Amy Hsu, Pamela Welch, Jennifer M Puck, Steven M Holland, Alexandra F Freeman.   

Abstract

PURPOSE: Autosomal Dominant Hyper IgE Recurrent Infection Syndrome (AD-HIES) is caused by mutations in STAT3 and characterized by eczema, recurrent bacterial infections, and skeletal and connective tissue abnormalities. To further understand the minimal trauma fractures of AD-HIES, we examined bone mineral density (BMD) and laboratory markers of bone turnover.
METHODS: Patients with AD-HIES enrolled in a prospective natural history study were examined with dual x-ray absorptiometry (DEXA) scans and laboratory studies of bone metabolism. The number of fractures was recorded as well as clinical features of AD-HIES including scoliosis and retained primary teeth. Patients on medications with skeletal effects, including bisphosphonates, were examined separately.
RESULTS: Twenty-three AD-HIES children (6-18 years) and 33 AD-HIES adults (21-50 years) not receiving bone-active drugs were studied. Fourteen of the 23 children (61%) had histories of minimal trauma fractures, as did 26 of the 33 adults (79%). Osteopenia or osteoporosis was found in 79% of children and adults. Only radial BMD correlated with the qualitative occurrence of fractures but it did not correlate with the numbers of fractures. Markers of bone metabolism did not correlate with minimal trauma fractures or BMD. Patients on bone-active medications had improved BMD, but still sustained fractures.
CONCLUSIONS: Minimal trauma fractures and decreased BMD are common in AD-HIES. Low radial BMD is associated with fractures, but hip and spine BMD are not. Treatment with bisphosphonates increased BMD but its role in fracture prevention remains undefined.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24402620      PMCID: PMC4484798          DOI: 10.1007/s10875-013-9982-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  6 in total

1.  Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.

Authors:  Yoshiyuki Minegishi; Masako Saito; Shigeru Tsuchiya; Ikuya Tsuge; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Srdjan Pasic; Oliver Stojkovic; Ayse Metin; Hajime Karasuyama
Journal:  Nature       Date:  2007-08-05       Impact factor: 49.962

2.  STAT3 mutations in the hyper-IgE syndrome.

Authors:  Steven M Holland; Frank R DeLeo; Houda Z Elloumi; Amy P Hsu; Gulbu Uzel; Nina Brodsky; Alexandra F Freeman; Andrew Demidowich; Joie Davis; Maria L Turner; Victoria L Anderson; Dirk N Darnell; Pamela A Welch; Douglas B Kuhns; David M Frucht; Harry L Malech; John I Gallin; Scott D Kobayashi; Adeline R Whitney; Jovanka M Voyich; James M Musser; Cristina Woellner; Alejandro A Schäffer; Jennifer M Puck; Bodo Grimbacher
Journal:  N Engl J Med       Date:  2007-09-19       Impact factor: 91.245

3.  Extreme hyperimmunoglobulinemia E and undue susceptibility to infection.

Authors:  R H Buckley; B B Wray; E Z Belmaker
Journal:  Pediatrics       Date:  1972-01       Impact factor: 7.124

4.  Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder.

Authors:  B Grimbacher; S M Holland; J I Gallin; F Greenberg; S C Hill; H L Malech; J A Miller; A C O'Connell; J M Puck
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

5.  Osteoporosis with increased osteoclastogenesis in hematopoietic cell-specific STAT3-deficient mice.

Authors:  Zhiyuan Zhang; Thomas Welte; Nancy Troiano; Stephen E Maher; Xin-Yuan Fu; Alfred L M Bothwell
Journal:  Biochem Biophys Res Commun       Date:  2005-03-18       Impact factor: 3.575

6.  Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome.

Authors:  M Cohen-Solal; A M Prieur; L Prin; M A Denne; J M Launay; A M Graulet; M Brazier; C Griscelli; M C de Vernejoul
Journal:  Clin Immunol Immunopathol       Date:  1995-07
  6 in total
  12 in total

Review 1.  When Low Bone Mineral Density and Fractures Is Not Osteoporosis.

Authors:  Smita Jha; Marquis Chapman; Kelly Roszko
Journal:  Curr Osteoporos Rep       Date:  2019-10       Impact factor: 5.096

2.  Autosomal Dominant Hyper-IgE Syndrome in the USIDNET Registry.

Authors:  Yael Gernez; Alexandra F Freeman; Steven M Holland; Elizabeth Garabedian; Niraj C Patel; Jennifer M Puck; Kathleen E Sullivan; Javeed Akhter; Elizabeth Secord; Karin Chen; Rebecca Buckley; Elie Haddad; Hans D Ochs; Ramsay Fuleihan; John Routes; Mica Muskat; Patricia Lugar; Julien Mancini; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-19

3.  Hemoptysis in a Patient with Elevated Immunoglobulin E.

Authors:  Yael Gernez; Angela Tsuang; Tukisa D Smith; Khurram Shahjehan; Yiqun Hui; Paul J Maglione; Charlotte Cunningham-Rundles
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-29

Review 4.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

Review 5.  STAT3 signaling in immunity.

Authors:  Emily J Hillmer; Huiyuan Zhang; Haiyan S Li; Stephanie S Watowich
Journal:  Cytokine Growth Factor Rev       Date:  2016-05-09       Impact factor: 7.638

6.  An Unusual Pattern of Premature Cervical Spine Degeneration in STAT3-LOF.

Authors:  Amelia L Mitchell; Amanda K Urban; Alexandra F Freeman; Dima A Hammoud
Journal:  J Clin Immunol       Date:  2021-01-06       Impact factor: 8.317

Review 7.  STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.

Authors:  Christo Tsilifis; Alexandra F Freeman; Andrew R Gennery
Journal:  J Clin Immunol       Date:  2021-05-01       Impact factor: 8.317

8.  Stat3 in osteocytes mediates osteogenic response to loading.

Authors:  Kylie A Corry; Hongkang Zhou; Tatiana Brustovetsky; Evan R Himes; Nicoletta Bivi; M Ryne Horn; Yukiko Kitase; Joseph M Wallace; Teresita Bellido; Nickolay Brustovetsky; Jiliang Li
Journal:  Bone Rep       Date:  2019-07-29

Review 9.  Does Allergy Break Bones? Osteoporosis and Its Connection to Allergy.

Authors:  Maria Maddalena Sirufo; Mariano Suppa; Lia Ginaldi; Massimo De Martinis
Journal:  Int J Mol Sci       Date:  2020-01-21       Impact factor: 5.923

Review 10.  The JAK1/STAT3/SOCS3 axis in bone development, physiology, and pathology.

Authors:  Natalie A Sims
Journal:  Exp Mol Med       Date:  2020-08-13       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.